$HELE

Helen of Troy shareholders approved the board and pay plan. CEO Uzzell outlined a multi-year roadmap to stabilize the business, focusing on brand re-energization, consumer adaptation, and portfolio strengthening. The company faced challenges in fiscal 2026, including tariffs and changing trade patterns, but maintained cost discipline and generated strong cash flow. Uzzell characterized fiscal 2027 as a foundation year for the roadmap, with plans to reinvest in businesses and implement a general-

OXO, a Helen of Troy (Nasdaq: HELE) brand, launched a new pet feeding collection on Aug. 3, 2026, with items including nonslip bowls, slow-feeder bowls, a feeding mat, and an adjustable elevated feeder. A pet food storage line is planned for late 2026, featuring airtight containers and food storage with scoops. Products will be sold at major retailers, oxo.com, and Amazon.

Paradigm Capital Management increased its stake in Helen of Troy Limited (NASDAQ:HELE) by 64.3% in Q1 to 927,100 shares, worth about $13.37M, per its SEC 13F. Other institutions also adjusted positions. HELE shares opened at $28.47; the company reported Q2 EPS of $0.17 on revenue of $402.12M and issued FY2027 EPS guidance of 3.250 to 3.750.

Investing.com reports Nasdaq up about 1% as chip stocks extend a rebound. SanDisk Corp-Exch (SNDK) rose 12.28% and Lam Research (LRCX) gained 6.95%, alongside other chip-related movers. Costco reported June net sales of $29.24B, up 10.6%. Ionis (IONS) fell after its heart disease trial missed a primary endpoint.

Helen of Troy (NASDAQ:HELE) reported Q1 call highlights: Beauty and Wellness sales rose 7%, with wellness growth led by Braun, Vicks, Honeywell and PUR, while some core beauty brands faced POS pressure. International sales rose 1.1% on Osprey distribution. Margins were pressured by tariffs; gross margin fell to 46%. Full-year net sales guidance raised to $1.759B-$1.831B; adjusted EPS kept at $3.25-$3.75.

Helen of Troy (HELE) reported Q1 FY2027 net sales of $402.1 million, up 8.2%, with adjusted diluted EPS of $0.17. Gross margin fell to 46.0% due to tariffs and mix. The company raised full-year net sales guidance to $1.759B-$1.831B and maintained free cash flow guidance of $85M-$100M, citing Prime Day phasing and tariff refund expectations.

Helen of Troy (HELE) reported Q1 net sales of $402.1M, up 8.2% and above the $374.6M estimate. Adjusted EPS was 17 cents, ahead of expectations, but gross margin fell to 46.0% on tariff costs and mix. Operating cash flow and free cash flow were negative. The company raised FY2027 net sales guidance to $1.759B-$1.831B.

Helen of Troy (HELE) reported a surprise Q1 adjusted EPS of $0.17 versus a consensus loss of $0.01, with net sales up 8.2% to $402.1M, above forecasts. It raised fiscal 2027 revenue guidance to $1.76B-$1.83B, kept adjusted EPS at $3.25-$3.75. The company cited progress on Project Pegasus and tariff-related margin pressure.

Helen of Troy (HELE) reported fiscal Q1 2027 adjusted EPS of $0.17, versus a consensus $0.05 loss per share. Revenue rose 8.2% to $402.1 million, above the $368.53 million estimate. FY2027 revenue guidance was raised to $1.759B-$1.831B; adjusted EPS guidance stayed at $3.25-$3.75. Gross margin fell to 46.0% amid tariffs and mix effects.

Helen of Troy Ltd. (HELE) reported Q1 net income of $35.76M, or $1.51 per share, versus a year-ago net loss. Adjusted earnings were $0.17 per share. Q1 net sales rose 8.2% to $402.12M. For FY2027, the company kept EPS guidance at $3.57 to $4.18 and raised net sales to $1.759B to $1.831B.